Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Viking Therapeutics (GB:0VQA)
LSE:0VQA
Holding GB:0VQA?
Track your performance easily
Viking Therapeutics (0VQA) Ownership Overview
8.85% Insiders
30.59% Mutual Funds
31.03% Other Institutional Investors
29.54% Public Companies and
Individual Investors
The ownership structure of Viking Therapeutics (GB:0VQA) stock is a mix of institutional, retail and individual investors. Approximately 61.61% of the company’s stock is owned by Institutional Investors, 8.85% is owned by Insiders and 29.54% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jul 31, 2024 | Brian Lian President & Ceo,director | xxxxxxxxxxxxx | $6670604 |
| Jul 31, 2024 | xxxxxxxxxxxxx | $1029912 | |
| Jul 31, 2024 | Greg Zante Cfo | xxxxxxxxxxxxx | $922212 |
| Jan 04, 2024 | Greg Zante Cfo | xxxxxxxxxxxxx | $1380965 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2024 | xxxxxxxxxxxxx | $3468232 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $7787169 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $38240194 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $71799394 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 9,634,391 | Institution | 8.70% | 619,394,997 | |
| 9,118,405 | Institution | 8.23% | 586,222,257 | |
| 6,215,545 | Institution | 5.61% | 399,597,388 | |
| 5,819,383 | Insider | 5.25% | 374,128,133 | |
| 2,943,123 | Institution | 2.66% | 189,213,378 | |
| 2,304,927 | Insider | 2.08% | 148,183,757 | |
| 1,958,186 | Institution | 1.77% | 125,891,778 | |
| 1,755,137 | Institution | 1.58% | 112,837,758 | |
| 1,579,779 | Institution | 1.43% | 101,563,992 | |
| 1,354,450 | Institution | 1.22% | 87,077,591 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 9,118,405 | Institution | 8.23% | 586,222,257 | |
| 6,215,545 | Institution | 5.61% | 399,597,388 | |
| 1,958,186 | Institution | 1.77% | 125,891,778 | |
| 1,579,779 | Institution | 1.43% | 101,563,992 | |
| 1,181,345 | Institution | 1.07% | 75,948,670 | |
| 931,201 | Institution | 0.84% | 59,866,912 | |
| 753,487 | Institution | 0.68% | 48,441,679 | |
| 634,882 | Institution | 0.57% | 40,816,564 | |
| 540,957 | Institution | 0.49% | 34,778,126 | |
| 492,259 | Institution | 0.44% | 31,647,331 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Viking Therapeutics (GB:0VQA)?
According to the latest TipRanks data, approximately 31.03% of the company's stock is held by institutional investors, 8.85% is held by insiders, and 29.54% is held by retail investors.
What percentage of Viking Therapeutics (GB:0VQA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 31.03% of Viking Therapeutics (GB:0VQA) stock is held by institutional investors.
What percentage of Viking Therapeutics (GB:0VQA) stock is held by retail investors?
According to the latest TipRanks data, approximately 29.54% of Viking Therapeutics (GB:0VQA) stock is held by retail investors.
Who owns the most shares of Viking Therapeutics (GB:0VQA)?
Vanguard owns the most shares of Viking Therapeutics (GB:0VQA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.